SEC Form 3 · accession 0000899243-16-013063
PROTEOSTASIS THERAPEUTICS, INC. · PTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher T Walsh Ph.D.
Director
Period of report
Feb 10, 2016
Accepted (ET)
Feb 10, 2016 · 8:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001445283
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 6,012 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit List - Exhibit 24.1 - Power of Attorney